Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease.

Anna Maria Schneider; Daniel Weghuber; Benjamin Hetzer; Andreas Entenmann; Thomas Müller; Georg Johannes Zimmermann; Sebastian Schütz; Wolf-Dietrich Huber; Judith Pichler

doi:10.1186/s12876-018-0868-x

Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease.

Anna Maria Schneider (First author), Daniel Weghuber (Co-author), Benjamin Hetzer, Andreas Entenmann, Thomas Müller, Georg Johannes Zimmermann (Co-author), Sebastian Schütz, Wolf-Dietrich Huber, Judith Pichler

Research output: Contribution to journal › Original Article › peer-review

27 Citations (Web of Science)

Original language	English
Pages (from-to)	140
Journal	BMC GASTROENTEROLOGY
Volume	18
Issue number	1
DOIs	https://doi.org/10.1186/s12876-018-0868-x
Publication status	Published - 2018

Keywords

PEDIATRIC CROHNS-DISEASE
ULCERATIVE-COLITIS
MULTICENTER EXPERIENCE
MAINTENANCE THERAPY
INDUCTION THERAPY
ACTIVITY INDEX
EFFICACY
MODERATE
METAANALYSIS
REMISSION

Access to Document

10.1186/s12876-018-0868-x

Cite this

@article{5e8cda8bcc3347c4ae0ce483c68e2124,

title = "Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease.",

keywords = "PEDIATRIC CROHNS-DISEASE, ULCERATIVE-COLITIS, MULTICENTER EXPERIENCE, MAINTENANCE THERAPY, INDUCTION THERAPY, ACTIVITY INDEX, EFFICACY, MODERATE, METAANALYSIS, REMISSION",

author = "Schneider, {Anna Maria} and Daniel Weghuber and Benjamin Hetzer and Andreas Entenmann and Thomas M{\"u}ller and Zimmermann, {Georg Johannes} and Sebastian Sch{\"u}tz and Wolf-Dietrich Huber and Judith Pichler",

note = "Schneider, Weghuber: Paracelsus Med Univ, Dept Pediat, Salzburg, Austria; Zimmermann: Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr Salzburg, Salzburg, Austria",

year = "2018",

doi = "10.1186/s12876-018-0868-x",

language = "English",

volume = "18",

pages = "140",

journal = "BMC GASTROENTEROLOGY",

issn = "1471-230X",

number = "1",

}

TY - JOUR

T1 - Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease.

AU - Schneider, Anna Maria

AU - Weghuber, Daniel

AU - Hetzer, Benjamin

AU - Entenmann, Andreas

AU - Müller, Thomas

AU - Zimmermann, Georg Johannes

AU - Schütz, Sebastian

AU - Huber, Wolf-Dietrich

AU - Pichler, Judith

N1 - Schneider, Weghuber: Paracelsus Med Univ, Dept Pediat, Salzburg, Austria; Zimmermann: Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr Salzburg, Salzburg, Austria

PY - 2018

Y1 - 2018

KW - PEDIATRIC CROHNS-DISEASE

KW - ULCERATIVE-COLITIS

KW - MULTICENTER EXPERIENCE

KW - MAINTENANCE THERAPY

KW - INDUCTION THERAPY

KW - ACTIVITY INDEX

KW - EFFICACY

KW - MODERATE

KW - METAANALYSIS

KW - REMISSION

U2 - 10.1186/s12876-018-0868-x

DO - 10.1186/s12876-018-0868-x

M3 - Original Article

C2 - 30219028

SN - 1471-230X

VL - 18

SP - 140

JO - BMC GASTROENTEROLOGY

JF - BMC GASTROENTEROLOGY

IS - 1

ER -